Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
3.420
USD
-0.140 (-3.93%)
Official Closing Price
Updated: 7:54 PM EST, Jan 21, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Agenus Inc
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Agenus to Participate in B. Riley Securities' Oncology Investor Conference
January 19, 2021
From
GlobeNewswire News Releases
Completion of Balstilimab BLA Filing Extended To 1H2021
December 03, 2020
Agenus to fulfill FDA feedback for six-month follow-up on late responders
From
GlobeNewswire News Releases
Agenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with Balstilimab
December 01, 2020
New objective response in colon cancer triggers trial expansion
From
GlobeNewswire News Releases
Agenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference
November 25, 2020
From
GlobeNewswire News Releases
VBI Vaccines Announces Positive Interim Phase 2a Data from VBI-1901 in Recurrent GBM
November 19, 2020
VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI") a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced Phase 2a (Part B) data...
From
Business Wire News Releases
Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference
November 16, 2020
From
GlobeNewswire News Releases
Agenus and Dr. Steven O’Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data
November 13, 2020
From
GlobeNewswire News Releases
Agenus and Dr. Steven O’Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley
November 12, 2020
From
GlobeNewswire News Releases
XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement
November 11, 2020
From
GlobeNewswire News Releases
An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2
November 10, 2020
From
GlobeNewswire News Releases
Agenus Presents Additional Clinical Responses and Novel Biomarker Data at SITC2020
November 09, 2020
From
GlobeNewswire News Releases
Dr. Steven O’Day Named Agenus Chief Medical Officer
November 05, 2020
Immunotherapy Pioneer to Join As Company Ramps Up Commercialization and NextGen Clinical Pipeline Efforts
From
GlobeNewswire News Releases
Agenus Doses First COVID-19 Patient with iNKT Cell Therapy
November 02, 2020
From
GlobeNewswire News Releases
Agenus R&D Update & Third Quarter Financial Report
October 29, 2020
From
GlobeNewswire News Releases
Agenus to Report Third Quarter Earnings
October 20, 2020
Conference Call and Webcast on Thursday, October 29, 2020 from 8:30 – 9:30 am
From
GlobeNewswire News Releases
Agenus to Present on Seven Novel Programs at SITC 2020
October 14, 2020
From
GlobeNewswire News Releases
Susan Hirsch Joins Agenus’ Board of Directors
October 13, 2020
From
GlobeNewswire News Releases
Agenus Initiates Rolling BLA Submission of Balstilimab for Recurrent/Metastatic Cervical Cancer
September 18, 2020
From
GlobeNewswire News Releases
Agenus Presents Results from Two Large Cervical Cancer Trials at ESMO
September 18, 2020
From
GlobeNewswire News Releases
Dr. Jennifer Buell Speaks Live at Scientific American Inaugural Fireside Chat Series 18 Minutes With
September 17, 2020
From
GlobeNewswire News Releases
Agenus to Participate in Webcast Hosted by William Blair on ESMO2020 Results and Novel Pipeline
September 17, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Avinger, Vascular Biogenics, Intra-Cellular Therapies, Agenus, or Co-Diagnostics?
September 11, 2020
InvestorsObserver issues critical PriceWatch Alerts for AVGR, VBLT, ITCI, AGEN, and CODX.
From
PR Newswire
Paul Clark Joins Agenus Board of Directors
August 31, 2020
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapy, adjuvants, and vaccines designed to activate immune response to cancers and...
From
PR Newswire
Agenus Announces ESMO Oral Presentation of Two Clinical Trials of Balstilimab Alone and in Combination with Zalifrelimab in Recurrent or Metastatic Cervical Cancer
August 26, 2020
Data from two Phase 2 trials of balstilimab +/- zalifrelimab in patients with refractory cervical cancer were accepted as part of a late-breaking abstract and will be presented as an oral presentation...
From
PR Newswire
Agenus Provides R&D Update & Second Quarter Financial Report
August 06, 2020
- Dr. Chuck Drake & Dr. Bree Wilky to discuss AGEN1181 & zalifrelimab - new responses
From
PR Newswire
US Stocks That Surged Higher This Week: $AMRN $NAK $AGEN
August 05, 2020
Tags
The Market Signal
From
The Market Signal
Agenus to Present on Targeting Myeloid Cells in Tumor Microenvironment at the William Blair Biotech Focus 2020 Conference
August 04, 2020
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapy, adjuvants, and vaccines designed to activate immune response to cancers and...
From
PR Newswire
Agenus R&D update & Second Quarter Earnings Report
July 29, 2020
Video Meeting on Thursday August 6, 2020 from 8:30 - 10:30 am
From
PR Newswire
Agenus Receives $35M In Immuno-Oncology Transaction with Betta Pharmaceuticals
July 28, 2020
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with an extensive pipeline of agents designed to activate immune response to cancers, today announced the closing of a $20 million equity...
From
PR Newswire
Agenus To Participate in a Panel on Cell Therapy for Infectious Diseases at the B. Riley Virtual Infectious Disease Summit
July 21, 2020
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies and cancer vaccines, announced today that Dr. Jennifer Buell,...
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.